Archive
Newsletters
November 18, 2025
Newsletter: Edition Q3 2025
A team from UniQuest joined research commercialisation professionals from across New Zealand and Australia at the annual Knowledge Commercialisation Australasia conference, where UQ spin-out Vicebio was awarded Best Spin-Out of 2025.
April 10, 2025
Newsletter: Edition Q2 2025
A team from UniQuest joined others from across UQ to attend the BIO2025 International Convention at Boston in June, showcasing the brilliant technology from UQ researchers that is available for partnering and licensing on the world stage...
February 10, 2025
Newsletter: Edition Q1 2025
We are delighted to showcase the launch of Curlew Bio, the second biotech company founded through a partnership between UniQuest and global biotech Molecule to Medicine...
December 10, 2024
Newsletter: Edition Q4 2024
It is always exciting to take stock of the year that was and celebrate the incredible partnerships that came to fruition in 2024...
July 10, 2024
Newsletter: Edition Q3 2024
A highlight this quarter was the Series B capital raise of UQ start-up Vicebio, using molecular clamp technology invented by Professor Paul Young, Professor Keith Chappell and Professor Daniel Watterson...
April 10, 2024
Newsletter: Edition Q2 2024
A highlight this quarter was the acquisition of Ortelia, a UQ-founded start-up from the School of Communication and Arts, by Swiss company Culture Software Group...
February 10, 2024
Newsletter: Edition Q1 2024
We are kicking-off the first quarter with a feature on a solar panel monitoring technology developed by researchers at UQ. The platform has been spun-out into a new company called SolarisAI...
November 10, 2023
Newsletter: Edition Q4 2023
In this edition, we are celebrating the year that was and some of our exciting commercialisation outcomes. These include the announcement that UQ's drug discovery entity, the Queensland Emory Drug Discovery Initiative (QEDDI), will accept projects from external institutions for the first time...
July 15, 2023
Newsletter: Edition Q3 2023
In this edition, we are highlighting an exciting licensing deal to a global water company, as well as promising new developments from UQ researchers in partnership with our drug discovery entity, the Queensland Emory Drug Discovery Initiative (QEDDI)...
Featured news articles
September 30, 2026
Australia produces world-class research, but many university startups still struggle to secure the growth capital needed to scale. UniQuest CEO Dr Dean Moss explores whether Australia's challenge is a shortage of capital, or a shortage of appetite for risk.
September 23, 2026
Two UQ research teams supported by UniQuest have secured $4 million in CUREator+ funding to advance potential new therapies for Alzheimer’s disease and dementia, accelerating the journey from laboratory discovery towards clinical development.
September 21, 2026
A homegrown vaccine platform demonstrated in animals could soon become a ‘plug-and-play’ system to rapidly adapt to future mosquito-borne disease threats in humans.
June 19, 2026
A promising new treatment for advanced and therapy-resistant prostate cancer developed from research conducted at The University of Queensland has taken a major step towards the clinic.
